Pondy Oxides And Chemicals (532626) Q3 24/25 earnings summary

Executive summary

• Achieved strong financial and operational performance in Q3 and nine months FY 2025, with significant growth in revenue, EBITDA, and PAT year-over-year.

• Raised INR 175 crore via QIP to fund capacity expansion, working capital, and strategic initiatives, with partial utilization for asset purchases and the remainder in liquid assets.

• Major capacity expansion underway: phase I of 36,000 MT lead plant to commence trial production in March 2025; phase II expected by H2 FY 2026.

• Strategic focus on value-added products, sustainability, and expanding non-ferrous metal portfolio, aiming for value-added products to exceed 60% of revenue.

• Share face value reduced from ₹10 to ₹5 effective October 16, 2024.

Financial highlights

• Nine-month consolidated revenue up 30% YoY to INR 1,533 crore; EBITDA up 47% to INR 80 crore; PAT more than doubled to INR 41 crore (up 108%).

• Q3 consolidated revenue up 11% YoY to INR 509 crore; EBITDA up 11% to INR 26 crore; PAT up 31% to INR 13 crore.

• Q3FY25 standalone revenue rose 11% YoY to Rs. 5,024 million; 9MFY25 revenue up 29% YoY to Rs. 15,116 million.

• Q3FY25 PAT grew 21% YoY to Rs. 151 million; 9MFY25 PAT surged 73% YoY to Rs. 471 million.

• EPS (diluted) for 9MFY25 at Rs. 17, up 49% YoY; Q3 FY2025 EPS was ₹5.03 (basic), up from ₹4.36 in Q3 FY2024.

Outlook and guidance

• Targeting over 15% volume growth, 20%+ revenue CAGR, EBITDA margin above 8%, and ROCE above 20% by 2030.

• Q4 expected to see volume and sales rebound after seasonal Q3 dip; full-year volumes projected to surpass last year.

• Phase I lead plant to reach 80-85% utilization by Q1/Q2 FY 2026; phase II to add further capacity in H2 FY 2026.

• Plans to diversify into lithium-ion and other verticals, with continued focus on value-added products and ESG initiatives.

• QIP proceeds are expected to support future growth, with unutilized funds temporarily invested in liquid assets.